Clinical Trial Update: Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Pfizer is conducting a Phase 2 study of PF08634404 in combination with chemotherapy for transformed small cell lung cancer, and the trial is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• PF08634404

Snippet

Sponsor: Pfizer | Conditions: Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC ) | Phase 2 | Status: RECRUITING